Suppressor of cytokine signaling, skeletal muscle, and chronic health conditions: The potential interactions

Exercise and Sport Sciences Reviews

Volumn 35, Issue 3, 2007, Pages 156-162

  Spangenburg, Espen E ^a  

^a UNIVERSITY OF MARYLAND   (United States)

Author keywords

Activity; Adipokines; Cell; Gene; Mechanism

Indexed keywords

CYTOKINE;

CELL DIFFERENTIATION; CORRELATION ANALYSIS; EXERCISE; HEALTH; HUMAN; IMMUNOMODULATION; IMMUNOREGULATION; MULTIGENE FAMILY; MUSCLE FUNCTION; MUSCLE GROWTH; MYOBLAST; PRIORITY JOURNAL; PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TISSUE CHARACTERIZATION;

CHRONIC DISEASE; EXERCISE; HUMANS; MUSCLE, SKELETAL; PHYSICAL EDUCATION AND TRAINING; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; UNITED STATES;

EID: 34447297275     PISSN: 00916331     EISSN: None     Source Type: Journal    
DOI: 10.1097/jes.0b013e3180a02fe6     Document Type: Review

References (30)

1. Aguirre, V., T. Uchida, L. Yenush, R. Davis, and M.F. White. The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J. Biol. Chem. 275:9047-9054, 2000.
2. Carey, A.L., G.R. Steinberg, S.L. Macaulay, W.G. Thomas, A.G. Holmes, G. Ramm, O. Prelovsek, C. Hohnen-Behrens, M.J. Watt, D.E. James, B.E. Kemp, B.K. Pedersen, and M.A. Febbraio. Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase. Diabetes 55:2688-2697, 2006.
3. DeFronzo, R.A. Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 37:667-687, 1988.
4. Emanuelli, B., P. Peraldi, C. Filloux, C. Chavey, K. Freidinger, D.J. Hilton, G.S. Hotamisligil, and E. Van Obberghen. SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-alpha in the adipose tissue of obese mice. J. Biol. Chem. 276:47944-47949, 2001.
5. Emanuelli, B., P. Peraldi, C. Filloux, D. Sawka-Verhelle, D. Hilton, and E. Van Obberghen. SOCS-3 is an insulin-induced negative regulator of insulin signaling. J. Biol. Chem. 275:15985-15991, 2000.
6. Endo, T.A., M. Masuhara, M. Yokouchi, R. Suzuki, H. Sakamoto, K. Mitsui, A. Matsumoto, S. Tanimura, M. Ohtsubo, H. Misawa, T. Miyazaki, N. Leonor, T. Taniguchi, T. Fujita, Y. Kanakura, S. Komiya, and A. Yoshimura. A new protein containing an SH2 domain that inhibits JAK kinases. Nature 387:921-924, 1997.
7. Garma, T.M., C.A. Kobayashi, F. Haddad, G.R. Adams, P.W. Bodell, and K.M. Baldwin. Similar acute molecular responses to equivalent volumes of isometric, lengthening or shortening mode resistance exercise. J. Appl. Physiol. 102:135-143, 2007.
8. Greenhalgh, C.J., D. Metcalf, A.L. Thaus, J.E. Corbin, R. Uren, P.O. Morgan, L.J. Fabri, J.G. Zhang, H.M. Martin, T.A. Willson, N. Billestrup, N.A. Nicola, M. Baca, W.S. Alexander, and D.J. Hilton. Biological evidence that SOCS-2 can act either as an enhancer or suppressor of growth hormone signaling. J. Biol. Chem. 277: 40181-40184, 2002.
9. Haddad, F., and G.R. Adams. Aging-sensitive cellular and molecular mechanisms associated with skeletal muscle hypertrophy. J. Appl. Physiol. 100:1188-1203, 2006.
10. Haddad, F., F. Zaldivar, D.M. Cooper, and G.R. Adams. IL-6-induced skeletal muscle atrophy. J. Appl. Physiol. 98:911-917, 2005.
11. Horsley, V., K.M. Jansen, S.T. Mills, and G.K. Pavlath. IL-4 acts as a myoblast recruitment factor during mammalian muscle growth. Cell 113:483-494, 2003.
12. Horvat, S., and J.F. Medrano. Lack of SOCS2 expression causes the high-growth phenotype in mice. Genomics 72:209-212, 2001.
13. Hotamisligil, G.S., N.S. Shargill, and B.M. Spiegelman. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259:87-91, 1993.
14. Kami, K., and E. Senba. In vivo activation of STAT3 signaling in satellite cells and myofibers in regenerating rat skeletal muscles. J. Histochem. Cytochem. 50:1579-1589, 2002.
15. Klover, P.J., A.H. Clementi, and R.A. Mooney. Interleukin-6 depletion selectively improves hepatic insulin action in obesity. Endocrinology 146:3417-3427, 2005.
16. Metcalf, D., C.J. Greenhalgh, E. Viney, T.A. Willson, R. Starr, N.A. Nicola, D.J. Hilton, and W.S. Alexander. Gigantism in mice lacking suppressor of cytokine signalling-2. Nature 405:1069-1073, 2000.
17. Naka, T., M. Narazaki, M. Hirata, T. Matsumoto, S. Minamoto, A. Aono, N. Nishimoto, T. Kajita, T. Taga, K. Yoshizaki, S. Akira, and T. Kishimoto. Structure and function of a new STAT-induced STAT inhibitor. Nature 387:924-929, 1997.
18. Paoni, N.F., F. Peale, F. Wang, C. Errett-Baroncini, H. Steinmetz, K. Toy, W. Bai, P.M. Williams, S. Bunting, M.E. Gerritsen, and L. Powell-Braxton. Time course of skeletal muscle repair and gene expression following acute hind limb ischemia in mice. Physiol. Genomics 11:263-272, 2002.
19. Pedersen, B.K., M.A. Febbraio, and R.A. Mooney. Point: interleukin-6 does/does not have a beneficial role in insulin sensitivity and glucose homeostasis. J. Appl. Physiol. 102:814-816, 2007.
20. Petersen, A.M., and B.K. Pedersen. The anti-inflammatory effect of exercise. J. Appl. Physiol. 98:1154-1162, 2005.
21. Rui, L., M. Yuan, D. Frantz, S. Shoelson, and M.F. White. SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J. Biol. Chem. 277:42394-42398, 2002.
22. Senn, J.J., P.J. Klover, I.A. Nowak, T.A. Zimmers, L.G. Koniaris, R.W. Furlanetto, and R.A. Mooney. Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes. J. Biol. Chem. 278:13740-13746, 2003.
23. Spangenburg, E.E. SOCS-3 induces myoblast differentiation. J. Biol. Chem. 280:10749-10758, 2005.
24. Spangenburg, E.E., and F.W. Booth. Leukemia inhibitory factor restores the hypertrophic response to increased loading in the LIF(-/-) mouse. Cytokine 34:125-130, 2006.
25. Spangenburg, E.E., D.A. Brown, M.S. Johnson, and R.L. Moore. Exercise increases SOCS-3 expression in rat skeletal muscle: potential relationship to IL-6 expression. J. Physiol. 572:839-848, 2006.
26. Starr, R., T.A. Willson, E.M. Viney, L.J. Murray, J.R. Rayner, B.J. Jenkins, T.J. Gonda, W.S. Alexander, D. Metcalf, N.A. Nicola, and D.J. Hilton. A family of cytokine-inducible inhibitors of signalling. Nature 387:917-921, 1997.
27. Summers, P.J., and J.F. Medrano. Morphometric analysis of skeletal muscle growth in the high growth mouse. Growth Dev. Aging 58:135-148, 1994.
28. Summers, P.J., and J.F. Medrano. Delayed myogenesis associated with muscle fiber hyperplasia in high-growth mice. Proc. Soc. Exp. Biol. Med. 214:380-385, 1997.
29. Tidball, J.G., and M. Wehling-Henricks. Macrophages promote muscle membrane repair and muscle fibre growth and regeneration during modified muscle loading in mice in vivo. J. Physiol. 578:327-336, 2007.
30. Trenerry, M.K., K.A. Carey, A.C. Ward, and D. Cameron-Smith. STAT3 signaling is activated in human skeletal muscle following acute resistance exercise. J. Appl. Physiol. 102:1483-1489, 2007.